Orthobiologics market report for 2018 explored in latest research

1. Orthobiologics Market - Size, Share, Growth, Orthobiologics Market - Size, Share, Growth, Outlook, and Opportunity Analysis, 2018-2026 Outlook, and Opportunity Analysis, 2018-2026 Orthobiologics are substances used to heal injuries such as fractures and injured muscles, ligaments, and tendons within a short period of time. Orthobiologics are made from substances that naturally occur in the body. Some examples of orthobiologics are bone grafts, autologous blood, autologous conditioned serum, platelet rich plasma, growth factors, and stem cells. Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1306 Increasing prevalence of injury and facture due to falls and road accidents are expected to augment growth of the orthobiologics market According to World Health Organization (WHO), 2017, fatal falls are the second-leading cause of accidental injury and factures worldwide. Every year around 646000 individuals die from falls, globally. Increasing incidence of fall is expected to increase the chances of fractures, which in turn, is expected to create a highly conductive environment for growth of the orthobiologics market over the forecast period. According to World Health Organization (WHO), in 2017, around 1.25 million deaths were recorded and 20 to 50 million people suffered from severe injuries and fractures. Increasing prevalence of factures due to road accidents is expected to boost growth of the orthobiologics market in the near future. According to National Institute of Health (NIH), in 2016, around 8.5%, accounting for around 617 million of the world population was aged 65 years and above. Growing geriatric population, which is highly susceptible to injuries and fractures due to fragile skeletal framework, is increasing the prevalence of orthopedic disorders, in turn, driving growth of the orthobiologics market. The major factor restraining market growth is the high cost associated with orthobiologics-based treatments. North America is expected to hold a dominant position due to rapid development of new innovative products by key players present in region

2. North America is expected to hold a dominant position in the orthobiologics market due to rampant research activities and rapid development of innovative products by key players present in the region. For instance, in 2015, NuVasive Inc.—U.S.-based company—launched its new innovative biologics technology, AttraX Putty, which is a synthetic bone graft, indicated in posterolateral spinal surgery as an autograft extender. Asia Pacific is expected to witness rapid growth, owing to growing geriatric population in the region. According to The United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), 2016, the Asia Pacific region recorded around 60 percent of the geriatric population across the globe. The region recorded around 547 million people aged 65 years and above, which is projected to reach up to 1.3 billion by 2050. Report includes chapters which deeply display the following deliverable about industry : • Orthobiologics Market Research Objective and Assumption • Orthobiologics Market Purview - Report Description, Executive Summary, and Coherent Opportunity Map (COM) • Orthobiologics Market Dynamics, Regulations, and Trends Analysis - Market Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis • Global Orthobiologics Market, By Regions • Orthobiologics Market Competition by Manufacturers including Production, Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type. • Orthobiologics Market Manufacturers Profiles/Analysis including Company Basic Information, Manufacturing Base and Its Competitors. • Orthobiologics Market Manufacturing Cost Analysis including Key Raw Materials and Key Suppliers of Raw Materials. • Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials Sourcing and Downstream Buyers • Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market Positioning and Distributors/Traders List. • Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer Preference Change and Economic/Political Environmental Change. • Orthobiologics Market Forecast including Production, Consumption, Import and Export Forecast by Type, Applications and Region. • Research Findings and Conclusion Key players operating in the orthobiologics market include Medtronic Plc, DePuy Synthes, Inc., Zimmer Biomet Holdings, Inc., Bone Biologics Corp, Harvest Technologies Corporation, Globus Medical, Inc., Smith & Nephew plc. NuVasive Inc., Stryker Corporation, and Genzyme

3. Inquire Here Before Purchase: https://www.coherentmarketinsights.com/insight/talk-to-analyst/1306 Global Orthobiologics Market Taxonomy The global orthobiologics market is segmented on the basis of product type, application, and end user. By Product Type Demineralized Bone Matrix (DBM) Allograft Bone Morphogenetic Protein (BMP) Viscosupplementation Products Synthetic Bone Substitutes Stem Cell Therapy • • • • • • By Application Osteoarthritis and Degenerative Arthritis Spinal Fusion Fracture Recovery Soft Tissue Injuries Maxillofacial and Dental Applications • • • • • By End User Hospitals Ambulatory Care Centers Dental Clinics • • • About Coherent Market Insights Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us Mr. Shah

4. Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com